<DOC>
	<DOCNO>NCT03033355</DOCNO>
	<brief_summary>The purpose prospective research study evaluate high neural change follow intradetrusor injection Botulinum toxin-A ( BTX-A ) patient Multiple Sclerosis ( MS ) . Concurrent Urodynamic Functional Magnetic Resonance ( fMRI ) data record pre- post- intravesical injection BTX-A patient Multiple Sclerosis ( MS ) neurogenic detrusor activity ( NDO ) . Other objective evaluate role urinary biomarkers brain-derived neurotropic factor ( BDNF ) nerve growth factor ( NGF ) associate bladder overactivity , determine whether common validate urgency questionnaire correlate fMRI finding urinary biomarker concentration pre- post- BTX-A injection patient MS NDO .</brief_summary>
	<brief_title>Central Nervous System Changes Following BotulinumtoxinA Injection Bladder</brief_title>
	<detailed_description>Multiple Sclerosis severe debilitate disease affect patient 's quality life . Up 90 % patient MS develop low urinary tract dysfunction within first 18 year disease . Lower urinary tract symptom ( LUTS ) range urgency urge urinary incontinence and/or hesitancy incomplete bladder empty . Urgency , frequency , neurogenic detrusor overactivity ( NDO ) common urologic finding ( 34-99 % ) diagnostic evaluation patient MS . Even though anticholinergic beta agonist drug limit effectiveness adverse side effect , first line pharmacotherapy patient NDO behavioral modification pelvic floor physical therapy unsuccessful . Botulinum toxin-A ( BTX-A ) intradetrusor injection highly effective treatment option patient NDO refractory conservative management . BTX-A block release acetylcholine neuromuscular junction lead temporary chemodenervation bladder ( paralysis muscle ) . Motor effect BTX-A bladder extensively study widely report literature , US Food Drug Administration approve BTX-A treatment detrusor overactivity neurogenic non-neurogenic patient . However , sensory effect BTX-A injection correlate central nervous system regional perception/localization urgency , frequency , urge incontinence human well know . Over past decade , functional MRI ( fMRI ) use study activation supraspinal low urinary tract control center healthy subject storage void phase . Given fact , investigator interest evaluate role intradetrusor injection BTX-A afferent response patient MS NDO . High-resolution neuroimaging technique help investigator understand MS affect bladder-brain control . This study use fMRI task-related blood oxygen level dependent ( BOLD ) signal evaluate patient MS NDO prior , 6-10 week intradetrusor injection BTX-A simultaneous urodynamic evaluation . Clinical correlation woman chronic urologic problem new discovery level CNS activity give good understand disorder , lead development effective diagnostic treatment modality .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Urinary Bladder , Neurogenic</mesh_term>
	<mesh_term>Urinary Incontinence , Urge</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Patients clinical diagnosis neurogenic bladder . History neurologic illness injury ( include limit spinal cord injury , Multiple Sclerosis , spina bifida , Parkinson 's , major spine surgery ) . 18 year old . Female patient . Male History incontinence surgery ( sling , MMK , Burch ) . History low urinary tract surgery manipulation ( urethral dilation ) . Positive urine pregnancy test enrollment .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Neurogenic Bladder , Detrusor Overactivity , Botox , fMRI , neurogenic detrusor overactivity</keyword>
</DOC>